Technology

The SAVINE technology is a method for designing synthetic vaccines that stimulates and enhances the body’s immune system. Synthetic genes are designed and constructed such that they encode ‘scrambled’ protein sequences from infectious agents or cancers, packaged appropriately for delivery to the body using standard genetic-based delivery vectors. This technology is owned by SAVINE Therapeutics Pty Ltd and is covered by the patent:

• “Synthetic peptide and uses therefore” WO/2001/090197